Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Gastric Adenocarcinoma × Tadalafil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 2 Urogenital Neoplasms 1 Gastric Adenocarcinoma 1 Erectile Dysfunction 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 2 Gastrectomy 2 trastuzumab deruxtecan 1 taxane 1 sintilimab 1 durvalumab 1 Taxes 1 Tadalafil 1 Platinum 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Immunotherapy, Adoptive 1 Drug Therapy 1 Cytoreduction Surgical Procedures 1 Cisplatin 1 Albumin-Bound Paclitaxel 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05709574 2025-10-16

Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer

University of Arizona

Phase 2 Recruiting

Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡